MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer

A review of expression profiling of circulating microRNAs in men with prostate cancer

(2012) Brian D. Kelly et al.   BJU INTERNATIONAL

Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study

(2012) Ju-Fang Shi et al.   BMC HEALTH SERVICES RESEARCH

Role of MicroRNAs in Lung Cancer

(2012) Mattia Boeri et al.   CANCER JOURNAL

MicroRNAs: molecular features and role in cancer

(2012) Elodie Lages   Frontiers in Bioscience-Landmark

Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review

(2012) Viswam S. Nair et al.   JNCI-Journal of the National Cancer Institute

microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review)

(2012) YAN-WEN JIANG et al.   Molecular Medicine Reports

The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer

(2011) A. Uesugi et al.   CANCER RESEARCH

Rheb/mTOR Activation and Regulation in Cancer: Novel Treatment Strategies beyond Rapamycin

(2011) Justin T. Babcock et al.   CURRENT DRUG TARGETS

Prioritizing human cancer microRNAs based on genes’ functional consistency between microRNA and cancer

(2011) Xia Li et al.   NUCLEIC ACIDS RESEARCH

MicroRNAs as a potential prognostic factor in gastric cancer

(2011) Baruch Brenner   WORLD JOURNAL OF GASTROENTEROLOGY

Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells

(2010) Dong-Jun Peng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case–control study in Chinese women

(2010) Xiaoyi Zhou et al.   GYNECOLOGIC ONCOLOGY

Activation of mTOR signaling pathway contributes to survival of cervical cancer cells

(2010) Jing Ji et al.   GYNECOLOGIC ONCOLOGY

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review)

(2010) MEGUMI YANOKURA et al.   Oncology Letters

MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor

(2010) Jun Tie et al.   PLoS Genetics

AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001

(2009) M. Marinov et al.   CLINICAL CANCER RESEARCH

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells

(2009) Pedro M. Borralho et al.   FEBS Journal

Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition

(2009) M. Breuleux et al.   MOLECULAR CANCER THERAPEUTICS

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways

(2009) C Guo et al.   ONCOGENE

Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins

(2008) Medhi Wangpaichitr et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A microRNA DNA methylation signature for human cancer metastasis

(2008) A. Lujambio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA